LBF20203PG01: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
|SysName=9-oxo-11alpha,15S-dihydroxy-prosta-13E,17Z-dien-1-oic acid | |SysName=9-oxo-11alpha,15S-dihydroxy-prosta-13E,17Z-dien-1-oic acid | ||
|Common Name=&&Delta^{17}-Prostaglandin E_1&&9-oxo-11alpha,15S-dihydroxy-prosta-13E,17Z-dien-1-oic acid&& | |Common Name=&&Delta^{17}-Prostaglandin E_1&&9-oxo-11alpha,15S-dihydroxy-prosta-13E,17Z-dien-1-oic acid&& | ||
|Source=<FONT FACE="Symbol">D</FONT><SUP><FONT SIZE=-1>1</FONT></SUP><SUP><FONT SIZE=-1>7</FONT></SUP>-PGE1 is produced by the cyclooxigenase metabolism of <FONT FACE="Symbol">w</FONT>-3 arachidonic acid. | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 22:00, 24 November 2009
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1706 |
| LipidMaps | LMFA03010143 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20203PG01 |
| Δ17-Prostaglandin E1 | |
|---|---|
| |
| Structural Information | |
| 9-oxo-11α,15S-dihydroxy-prosta-13E,17Z-dien-1-oic acid | |
| |
| Formula | C20H32O5 |
| Exact Mass | 352.224974134 |
| Average Mass | 352.46508 |
| SMILES | C(=CC[C@@H](O)C=C[C@H]([C@H]1CCCCCCC(O)=O)[C@@H](CC1=O)O)CC |
| Physicochemical Information | |
| D17-PGE1 is produced by the cyclooxigenase metabolism of w-3 arachidonic acid. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
